Simplex Trading’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.3M | Sell |
989,200
-359,300
| -27% | -$16.8M | 0.03% | 224 |
|
|
2025
Q4 | $39.8M | Sell |
1,348,500
-304,600
| -18% | -$8.28M | 0.02% | 337 |
|
|
2025
Q3 | $42.7M | Buy |
1,653,100
+26,300
| +2% | +$734K | 0.02% | 390 |
|
|
2025
Q2 | $44.9M | Buy |
1,626,800
+496,400
| +44% | +$13.1M | 0.03% | 314 |
|
|
2025
Q1 | $32M | Buy |
1,130,400
+69,200
| +7% | +$2.46M | 0.02% | 379 |
|
|
2024
Q4 | $44.1M | Buy |
1,061,200
+41,700
| +4% | +$1.99M | 0.02% | 346 |
|
|
2024
Q3 | $68.1M | Buy |
1,019,500
+354,600
| +53% | +$32.6M | 0.04% | 236 |
|
|
2024
Q2 | $79M | Buy |
664,900
+23,200
| +4% | +$2.94M | 0.05% | 203 |
|
|
2024
Q1 | $68.4M | Buy |
641,700
+103,900
| +19% | +$10.5M | 0.04% | 257 |
|
|
2023
Q4 | $53.5M | Sell |
537,800
-193,500
| -26% | -$16.3M | 0.03% | 323 |
|
|
2023
Q3 | $75.5M | Buy |
731,300
+179,400
| +33% | +$20M | 0.06% | 192 |
|
|
2023
Q2 | $67.1M | Sell |
551,900
-140,700
| -20% | -$18.8M | 0.06% | 219 |
|
|
2023
Q1 | $106M | Sell |
692,600
-91,300
| -12% | -$15.1M | 0.09% | 149 |
|
|
2022
Q4 | $141M | Buy |
783,900
+286,000
| +57% | +$46.8M | 0.15% | 89 |
|
|
2022
Q3 | $58.9M | Buy |
497,900
+96,800
| +24% | +$14.7M | 0.07% | 209 |
|
|
2022
Q2 | $57.3M | Sell |
401,100
-154,500
| -28% | -$22.1M | 0.06% | 214 |
|
|
2022
Q1 | $95.7M | Buy |
555,600
+20,700
| +4% | +$3.48M | 0.09% | 159 |
|
|
2021
Q4 | $136M | Sell |
534,900
-76,200
| -12% | -$22.3M | 0.14% | 110 |
|
|
2021
Q3 | $144M | Buy |
611,100
+43,400
| +8% | +$16M | 0.13% | 92 |
|
|
2021
Q2 | $133M | Buy |
567,700
+564,063
| +15,509% | +$101M | 0.13% | 96 |
|
|
2021
Q1 | $47.6M | Sell |
3,637
-2,514
| -41% | -$364K | 0.09% | 139 |
|
|
2020
Q4 | $64.3M | Buy |
+6,151
| New | +$622K | 0.08% | 134 |
|
|
2020
Q3 | – | Sell |
-5,573
| Closed | -$35.8M | – | 8207 |
|
|
2020
Q2 | $35.8M | Buy |
5,573
+4,493
| +416% | +$246K | 0.06% | 186 |
|
|
2020
Q1 | $3.23M | Buy |
1,080
+230
| +27% | +$5.29K | 0.01% | 937 |
|
|
2019
Q4 | $1.66M | Sell |
850
-895
| -51% | -$15.9K | ﹤0.01% | 1641 |
|
|
2019
Q3 | $2.78M | Buy |
1,745
+765
| +78% | +$11.3K | 0.01% | 1072 |
|
|
2019
Q2 | $1.43M | Buy |
980
+955
| +3,820% | +$20.5K | ﹤0.01% | 1572 |
|
|
2019
Q1 | $50K | Buy |
25
+23
| +1,150% | +$427 | ﹤0.01% | 5005 |
|
|
2018
Q4 | $3K | Buy |
+2
| New | +$33 | ﹤0.01% | 6434 |
|
Other funds holding MRNA
VCM
VPM
Simplex Trading's MRNA Position: Q1 2026 in Review
Simplex Trading increased its Moderna (MRNA) stake by 145% in Q1 2026, buying an estimated $6.06M and bringing the position to 219,573 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #655.
Simplex Trading first reported a position in MRNA in Q4 2018 and has held it in 24 quarters since. The position peaked at $12.7M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Simplex Trading held 219,573 shares of Moderna worth $11.2M as of Q1 2026.
- Simplex Trading bought 129,897 Moderna shares in Q1 2026, an estimated $6.06M.
- Moderna made up 0.01% of Simplex Trading's portfolio in Q1 2026, its #655 holding.
- Simplex Trading first reported a position in Moderna in Q4 2018 and has held it in 24 quarters since.
- Simplex Trading's Moderna position peaked at $12.7M in Q1 2022.
- 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.